Make your own free website on

Home-HD Symptoms

Medications and Mental Disorders
Don't Forget-Quick Reminders
Picture of the NIMH logo

Medications and Mental Disorders

Medication publication cover - NIH 02-3929 This booklet, designed to help persons who use mental health services to be well informed about medications for mental illnesses, has been completely revised . Offers descriptions of mental illnesses and the medications prescribed for them, together with an alphabetical listing of medications, including all those that have been approved since the last edition of the booklet.

| View | Print (pdf format 40 pages, 424KB) |

NIH Publication No. 02-3929
Revised April 2002, Reprinted September 2002

FOR THE PUBLIC (Booklets, Fact Sheets, and Summaries)

  • Medications
    This booklet offers descriptions of mental illnesses and the medications prescribed for them, together with an alphabetical (by generic and trade) listing of medications.

  • Your Child and Medication


  • Information About St. John's Wort

  • PUBLIC ALERT ON ST. JOHN'S WORT - Adverse interactions have been reported between St John's wort (hypericum), an herbal product used to treat depression, and two drugs: indinavir, a protease inhibitor used to treat HIV and cyclosporine, a drug used to reduce the risk of organ transplant rejection. Potentially dangerous changes in drug effects can occur when medications such as cyclosporine (Neoral, Sandimmune), digoxin (Lanoxin, Lanoxicaps) and warfarin (Coumadin) are taken with hypericum extracts. Hypericum extracts can decrease the blood levels of antiretroviral medications that are used in the treatment of HIV infection, thus making these drugs less effective. Recent data show that the plasma levels of the protease inhibitor indinavir (Crixivan) were reduced by more than 50% by hypericum (St. Johns wort) products.

    Please view NIH News Release and FDA Public Health Advisory for Health Care Professionals for more


Updated: May 14, 2002  information.


    Conference and Workshop Summaries

  • Treatment of Depression - Newer Pharmacotherapies
    Evidence Report/Technology Assessment from the Agency for Health Care Research and Quality. Provides a comprehensive evaluation of the benefits and adverse effects of newer pharmacotherapies and herbal treatments for depressive disorders in adults and children.